Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

HRTX Relative to the S&P 500

HRTX Relative to the Sector

% of Revenue Generated in Each Quarter

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the Heron Therapeutics, Inc. (NASD:HRTX) seasonal charts above shows that a Buy Date of October 23 and a Sell Date of February 26 has resulted in a geometric average return of 11.36% above the benchmark rate of the S&P 500 Total Return Index over the past 20 years. This seasonal timeframe has shown positive results compared to the benchmark in 15 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 20 years by an average of 28.75% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Heron Therapeutics Inc is a biotechnology company,
developing products to address unmet medical needs. It is developing novel,
patient-focused solutions that apply its science and technologies to
already-approved pharmacological agents.

Stocks mentioned in this post: HRTX